Innate Pharma S.A. ADS (IPHA)
Company News
The non-Hodgkin's lymphoma market is expected to grow significantly between 2025-2034, driven by increasing incidence, advancements in targeted therapies, emerging treatments, and improved early detection efforts.
Innate Pharma (IPHA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The company's collaboration agreement with Sanofi could soon pay off.
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C. 180 Life Sciences Corp. (NASDAQ: ATNF) climbed 71% to $2.12. 180 Life Sciences announced closing of $6 million registered direct offering priced at-the-market und...
Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? 6 To Watch With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.